Form 8-K - Current report:
SEC Accession No. 0001641172-25-009273
Filing Date
2025-05-08
Accepted
2025-05-08 16:25:28
Documents
14
Period of Report
2025-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 36579
2 EX-99.1 ex99-1.htm EX-99.1 69976
  Complete submission text file 0001641172-25-009273.txt   285382

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE idxg-20250508.xsd EX-101.SCH 3018
4 XBRL LABEL FILE idxg-20250508_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE idxg-20250508_pre.xml EX-101.PRE 22361
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3477
Mailing Address WATERVIEW PLAZA, SUITE 310 2001 ROUTE 46 PARSIPPANY NJ 07054
Business Address WATERVIEW PLAZA, SUITE 310 2001 ROUTE 46 PARSIPPANY NJ 07054 412-224-6100
INTERPACE BIOSCIENCES, INC. (Filer) CIK: 0001054102 (see all company filings)

EIN.: 222919486 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24249 | Film No.: 25926669
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)